Wells Fargo's turnaround execution and asset-cap termination are balanced by its 10.0% CET1 capital floor, which limits near-term share repurchases. Trading at 1.82 times tangible book value, the shares fairly price normalized 2027 earnings of $8.03. We initiate coverage with a Hold rating and an $84.00 price target.
Key points
- $80.82 share price values Wells Fargo at 1.82 times tangible book value, fully capturing post-asset-cap balance-sheet expansion.
- 10.0% CET1 capital ratio sits at the bottom of management's operating target range, restricting near-term share buybacks.
- $8.03 projected 2027 diluted earnings per share supports our $84.00 price target, offering 4% upside.
The call
The current price requires Wells Fargo to sustain 16% returns on tangible common equity while compounding balance-sheet assets at high single digits. However, with the standardized CET1 ratio declining to 10.0% following bond portfolio mark-to-market losses, excess capital is depleted. Repurchase pace must moderate from $2.5 billion per quarter to organic retained capital.
Diluted earnings per share and forecast run-rate ($)- Reported diluted EPS ($)
- Analyst forecast ($)
Sources: Wells Fargo quarterly supplements (Q4 24-Q3 26) and analyst estimates (Q4 26E-Q4 27E).
We project 2027 diluted earnings per share of $8.03 as asset repricing lifts net interest income to $52.0 billion while headcount reductions keep expenses near $56.5 billion. Trading at 10.5 times forward earnings and 1.67 times projected tangible book value, the stock fairly discounts turnaround execution against cyclical credit normalization. We initiate at Hold.
Standardized Common Equity Tier 1 ratio vs. target floor (%)Sources: Wells Fargo quarterly supplements and analyst estimates.
Valuation
| Driver / Valuation Step | Value | Note |
|---|
| 2026E Diluted EPS | $7.36 | Reflects full-year net interest income of $49.9 billion |
| 2027E Diluted EPS | $8.03 | Assumes 4% net interest income growth to $52.0 billion |
| 2027E Tangible Book Value | $50.26 per share | Assumes $5.80 per share retained capital accretion |
| Target P/E Multiple | 10.5 times | In line with regional and large-cap bank peers |
| Implied P/TBV Multiple | 1.67 times | Reflects 15.5% normalized ROTCE against 10.5% cost of equity |
| 12-Month Price Target | $84.00 | Implies 3.9% price return versus current $80.82 |
A 10.5 times multiple fairly reflects a stabilized national franchise emerging from regulatory remediation. At 1.82 times tangible book value today, upside is constrained by limited capital distributions until bond marks recover. Risk-reward is balanced across the 12-month horizon.
Risks
- Capital floor constraints: Further long-term interest rate increases could widen bond paper losses, forcing management to pause share repurchases; monitored via quarterly accumulated other comprehensive income.
- Credit deterioration in commercial lending: Rising net charge-offs in commercial real estate and commercial loans could push provisions above $4.5 billion; monitored through nonperforming asset additions.
- Regulatory compliance scrutiny: Residual inquiries regarding lending compliance could increase legal expenses; monitored through regulatory disclosures in Form 10-Q filings.
What would change my mind
Rapid steepening of the yield curve that reverses bond marks and expands the net interest margin beyond 2.60% would prompt an upgrade to Buy.
